Market Scenario:
Ischemic heart disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease. According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Middle-East and Africa Ischemic heart Disease market is growing steadily. The market is growing at the CAGR of 3.1% and expected to reach to US$ 2.84 billion by 2022.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2585
The Middle East and Africa Ischemic heart disease Market – Overview
The Middle East and Africa Ischemic heart disease market are showing the steady growth; mainly owing to increase in consumption of smoking, diabetes mellitus and cholesterol levels. There are few more factors which lead the occurrence of Ischemic heart disease, such as Hypertension, Genetic and hereditary factors, sedentary lifestyle, and Stress.
According to, Dubai Health Authority, Heart disease causes three in every 10 deaths in the UAE. Also, according to the Centers for Disease Control and Prevention (CDC), around 17.7 million people died with CVD, which hold 31% of all global deaths. Whereas in Saudi Arabia its holds 6% of total death. Companies are continually inventing new treatment to capture the Middle East and Africa market. Thus, players focusing more on educating the public about diseases related to heart, symptom, and precaution in order to develop their brand image and awareness within the region. In this regards, Hamad Medical Corporation, in September 2016, launched heart health campaign, with the aim to educate the public on how to recognize the signs and symptoms of a heart attack and advice on what to do if a heart attack is suspected. The company also educated the public on how to improve their heart health by providing information about heart conditions and the importance of maintaining a healthy heart. These activities help them to keep ahead with their competitor.
The Middle East and Africa Ischemic heart disease Market - Regional Analysis
According to the World Health Organization (WHO), in 2015, over 1.1 billion people were smoking tobacco, and male population consumes more in comparison to female. Although it is declining worldwide, but in many countries, the prevalence of tobacco smoking appears to be increasing, especially in the WHO Eastern Mediterranean Region and the African Region. The most affected countries in the Middle East are Egypt, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia (SAU), United Arab Emirates (UAE) and Yemen and in Africa Algeria, and Tunisia. World organization is more focused in order to provide funds to the countries of this region in order to improve the quality of life.
UAE is the largest ischemic heart disease industry in MEA market owing to the presence of huge population suffering with disease related to heart. The rest of Africa market is, however the fastest growing with a huge unmet medical need and high rate of tobacco and alcohol consumption which leads the incidence of many diseases. Moreover, the government of these countries are looking support from developed and developing nation in order to get effective and advanced treatment at lower cost. Companies are also looking forward to this market owing to the huge gap between demand and supply of the patients. According to the report published by the Centers for Disease Control and Prevention (CDC), in 2015, CDC has worked with the Kingdom of Saudi Arabia from 20 years, along with the Ministry of Health, WHO, local partners, and other U.S. Government agencies in reducing the impact of emerging diseases by building capacity in areas such as laboratory systems and epidemiology, strengthen immunization services, respond to public health emergencies, and conduct surveillance, surveys, and studies.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585
No comments:
Post a Comment